Champions Oncology

CSBRNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$66.670 M

$4.79 -1.44%

Close of 6 Nov 2026

As of 6 Nov 2026, Champions Oncology (CSBR) has a market capitalization of $66.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$59.4M

#2658 by revenue

Earnings

-$1.18K

Loss-making

Shares outstanding

13,918,569

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#117OKYO PharmaOKYO$73.5M
#118Tenaya TherapeuticsTNYA$72.6M
#119Champions OncologyCSBR$66.7M
#120Cognition TherapeuticsCGTX$60.2M
#121Cardiff OncologyCRDF$58.9M

What if Champions Oncology were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,028,720

Per share 423,532× higher

Bitcoin $1.53T

$109,770.48

Per share 22,917× higher

Apple $5.02T

$360,366.25

Per share 75,233× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Champions Oncology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.